iPLEDGEThe new isotretinoin registry

iPledge timelines

• September: initial mailing to all prescribers• October: Registration by pre-populated form• Mid-October: Receive patient kits • November:

– iPLEDGE goes live, doctors activate in system– New pts start on iPLEDGE

• November/December: transition old pts from SMART to iPLEDGE or finish course by 12/31

• Jan 1, 2006: Not registered=no drug

iPLEDGE Background

• iPLEDGE is an mandatory FDA initiative• All manufacturers of isotretinoin under one

plan:– Ranbaxy - Sotret– Barr - Claravis– Genpharm (Bertek) - Amnesteem– Roche - Accutane

• Covance selected as vendor to design, build, implement and operate the enhanced iPLEDGE program

One Central Clearinghouse…One Program

iPLEDGE Clearinghous

e

Physician Data Entry

Registration, Education and Activation Process

All interested parties have responsibilities:

• Manufacturers• Wholesalers• Pharmacies• Prescribers• Patients

Distribution

• Manufacturers can only ship isotretinoin to registered wholesalers

• Wholesalers can only ship isotretinoin to registered pharmacies

• Registered pharmacies can only dispense isotretinoin when they receive iPLEDGE clearinghouse approval

How does a prescriber register and activate?

Prescriber Education Materials

• Registered Prescriber receives– Cover letter • User name and password• Prescriber educational materials• Office staff designee(s) registration form and

instructions• Activation instructions sheet

Designee Clarification

– Office staff designee--can enter information as an extension of an individual prescriber

– Office delegate • Doctors within a practice can designate each other to

ensure continuum of care• No need to change doctor’s name on registry• There is no limit on designation(s) allowed• Resident clinics

- Designees and delegates have their own numbers

How do I enroll each patient into iPLEDGE?

Patient Registration by Prescriber

– Logs onto system and enters:• usual demographic data• patient risk category (Male, WCBP, WNCBP)• Confirmation of consent form(s) and HIPAA completion

– Provide patient with iPLEDGE card– Provides and documents patient with counseling and

educational materials

Patient Registration (all groups)

• Registers with the iPLEDGE system• Attests that they have:

– signed Informed consent form(s)– received education and counseling on

isotretinoin & iPLEDGE requirements

Patient Registration (WCBP only)

• Additional informed consent• Attest that they understand:

– they should not become pregnant– they must use 2 forms of contraception for 30

days prior to, during and 30 days post-treatment

– they must have monthly laboratory pregnancy testing

– they must interact monthly with iPLEDGE system

Your patient needs to interact directly with iPLEDGE

iPLEDGE Program Walk-through

• Women of child bearing potential (WCBP)• Women not of child bearing potential (WNCBP)

and Males

WCBP Pre-Treatment

• Screening pregnancy test in prescriber’s office• Prescriber documents in system

– Patient registration– Informed consent form(s) completed– Patient education and counseling– Contraceptive methods discussed with patient– Date of negative screening pregnancy test (only

time office test is okay)

• Initiate or continue appropriate contraception

WCBP monthly• Laboratory-conducted pregnancy test

– Results forwarded to prescriber

– Lab must be CLIA certified

• Prescriber documents in system– Patient education & counseling

– Contraceptive methods (must match patient input)

– Pregnancy test results

• Prescriber provides prescription (paper, phone, fax, e-mail)

• Patient interacts with iPLEDGE system– Answers monthly educational questions

– Lists contraceptive methods (must match prescriber input)

WCBP – Completion of therapy

• Laboratory-conducted pregnancy test immediately upon treatment discontinuation

• Appropriate contraception continued for 30 days after last dose of isotretinoin

• Final laboratory-conducted pregnancy test 30 days post treatment discontinuation

• Pregnancy test results documented in system

Pre-Treatment (WNCBPs and Men)

• Prescriber enters into the system– Patient registration…men included– Informed consent form(s) completed– Patient education and counseling

• Prescriber provides prescription (paper, phone, fax, e-mail)

Each Treatment Month (WNCBPs and Males)

• Prescriber documents in system– Patient education & counseling

• Prescriber provides prescription (paper, phone, fax, e-mail)

• WNCBP and men do not need to interact monthly with system

Every month for WCBP:

Prescriber– Counsels pt, confirms

contraception– Logs onto system to:

• Enter 2 forms of contraception patient has agreed to use

• Enter negative pregnancy test result

• Confirm pt counselled 

• Patient– Has office visit and

counselling– Has pregnancy test– Logs onto system and

answers questions– Enters her 2 forms of

BC

What is counselling?

For everyone• Risks of birth defects• Don’t share drug• Don’t donate blood

Additional for WCBP• Don’t get pregnant• Use two forms of BC

Prescriber Notice

• All pregnancies should be reported directly to Covance through the iPLEDGE program– www.ipledgeprogram.com

or call 1-866-495-0654

What happens at the pharmacy?

Dispensing Isotretinoin(All Patients)

• Patient presents prescription to pharmacy within 7 days of the office visit– Can be paper, phone, fax, e-mail – No “yellow stickers” in iPLEDGE

• Pharmacist accesses iPLEDGE for prescription authorization

• If prescription authorized, isotretinoin dispensed at the pharmacy

• Pharmacy sticker prohibits sale after 7 days

Prescription NOT AuthorizedReason for NO Authorization

Instructions to PatientAt Pharmacy

Pregnancy test NOT entered

Contact prescriber

Prescriber has not confirmed 2 forms of birth

control

Contact prescriber

Patient counseling NOT confirmed

Contact prescriber

Patient NOT interacting with iPLEDGE

Patient to call iPLEDGE

Pregnancy results are positive

STOP taking medication and contact prescriber

immediately.

Transition Plan (cont.)November 1 to December 31, 2005• Explanatory leaflet for prescribers and

pharmacists to distribute to patients – Announces the launch of iPLEDGE– Encourages patients to talk to their physician– Provides information about iPLEDGE

If you have not received your iPLEDGE registration kit…log onto—www.ipledgeprogram.com or call 1-866-495-0654

How will we cope with iPLEDGE?

• Kubler Ross stages of grieving • Denial

– I’m going to put this off as long as possible

• Anger– Threaten to stop prescribing

• Reality– Remember how important isotretinoin is

• Acceptance– Realize that the system is really easy once you get

used to it